Indoramin Hydrochloride

盐酸吲哚拉明

Report date: 2022/09/08 16:56:46
NME

Base Information

Drug NameIndoramin Hydrochloride
Drug Alias NameindoraminumindoraminaindoramineWydoraBaratol +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsHypertensionProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsHypertensionProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeC02CA02